Pfizer Inc. today announced the election of James C. Smith to its Board
of Directors, effective immediately. Mr. Smith also was appointed to the
Corporate Governance and Science and Technology Committees of Pfizer’s
Board.
Mr. Smith, 54, is the President and Chief Executive Officer (CEO) of
Thomson Reuters and serves on its Board of Directors. Prior to his
appointment as CEO in January 2012, he held various leadership positions
at Thomson Reuters, including CEO and Chief Operating Officer (COO) of
Thomson Reuters Professional Division. Prior to the acquisition of
Reuters PLC by Thomson, he served as COO of Thomson and President and
CEO of Thomson Learning’s Academic and Reference Group.
Mr. Smith is a member of the International Business Council of the World
Economic Forum and the Board of Directors of the Brazil-U.S. Business
Council. He also serves on the International Advisory Boards of British
American Business and the Atlantic Council.
“We are pleased to have Jim Smith join Pfizer’s Board of Directors. He
brings leadership and operational and international business experience
to Pfizer’s Board, and will be an excellent asset to the company,”
stated Ian Read, Pfizer’s Chairman and Chief Executive Officer. “The
addition of Jim to our Board helps ensure that Pfizer will continue to
benefit from a breadth and variety of experience.”
Copyright Business Wire 2014